Q9Y618 (NCOR2_HUMAN) Homo sapiens (Human)
Nuclear receptor corepressor 2 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
34 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of HDAC3 bound to corepressor and inositol tetraphosphate |
Heteromer O15379; | 100 | 1×ZN; 1×ACT; 2×K; 2×GOL; 1×I0P; | |||
| Co-ordinates and 1H, 13C and 15N chemical shift assignments for the complex of GPS2 53-90 and SMRT … |
Heteromer Q13227; | 100 | ||||
| Crystal structure of PPARG and NCOR2 with BAY-4931, an inverse agonist (compound 6c) |
Heteromer P37231; | 100 | 1×O0U; 2×GOL; 1×CA; | |||
| Crystal structure of the human PPAR-alpha ligand-binding domain in complex with an antagonist GW647… |
Heteromer Q07869; | 100 | 1×471; | |||
| Crystal structure of the BCL6 BTB domain complexed with a SMRT co-repressor peptide |
Heteromer P41182; | 100 | ||||
| Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 |
Heteromer P19793; | 100 | ||||
| Crystal Structure of the mutant Human ROR gamma Ligand Binding Domain With rockogenin. |
Heteromer P51449; | 100 | 1×82R; | |||
| Ternary complex of Human ROR gamma Ligand Binding Domain With Compound T. |
Heteromer P51449; | 100 | 1×9P6; | |||
| Crystal structure of histone deacetylase 4 (HDAC4) in complex with a SMRT corepressor SP1 fragment |
Heteromer P56524; | 100 | 2×K; 2×ZN; | |||
| Crystal Structure of the mutant Human ROR gamma Ligand Binding Domain With JTE-151 |
Heteromer P51449; | 100 | 1×YAL; | |||
| Discovery of the Second Generation ROR gamma Inhibitors Composed of an Azole Scaffold. |
Heteromer P51449; | 100 | 1×AYO; | |||
| X-ray structure of human PPARalpha ligand binding domain-NCoR2 corepressor peptide co-crystals obta… |
Heteromer Q07869; | 100 | ||||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound SI-2) |
Heteromer P37231; | 100 | 1×Q5X; 1×SO4; | |||
| Crystal structure of PPARgamma ligand binding domain in complex with SMRT peptide and inverse agoni… |
Heteromer P37231; | 100 | 2×EEY; | |||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 6a) |
Heteromer P37231; | 100 | 1×O2O; | |||
| Crystal Structure of the mutant Human ROR gamma Ligand Binding Domain With Compound A. |
Heteromer G1RH57; | 100 | 1×82O; | |||
| Solution structure of the MYND domain from AML1-ETO complexed with SMRT, a corepressor |
Heteromer Q06455; | 100 | 2×ZN; | |||
| Crystal structure of PPARG and NCOR2 with SR10221, an inverse agonist |
Heteromer P37231; | 100 | 1×A8R; | |||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 7a) |
Heteromer P37231; | 100 | 1×Q2X; 1×GOL; | |||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 15b) |
Heteromer P37231; | 100 | 1×Q8F; | |||
| PPAR gamma LBD bound to SR10221 and SMRT corepressor motif |
Heteromer P37231; | 100 | 1×A8R; | |||
| Crystal structure of histone deacetylase 4 (HDAC4) in complex with a SMRT corepressor SP2 fragment |
Heteromer P56524; | 100 | 2×K; 2×ZN; | |||
| Crystal structure of PPARG and NCOR2 with BAY-5516, an inverse agonist |
Heteromer P37231; | 100 | 1×Q5O; | |||
| Crystal structure of PPARG and NCOR2 with BAY-9683, an inverse agonist |
Heteromer P37231; | 100 | 1×Q4C; | |||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 7e) |
Heteromer P37231; | 100 | 1×Q33; | |||
| Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 7d) |
Heteromer P37231; | 100 | 1×Q1R; | |||
| Crystal structure of mutant PPARG (C313A) and NCOR2 with an inverse agonist (compound 7e) |
Heteromer P37231; | 100 | 1×Q33; | |||
| Crystal structure of mutant PPARG (C313A) and NCOR2 with an inverse agonist (compound SI-1) |
Heteromer P37231; | 100 | 1×Q4O; | |||
| Progesterone receptor with bound ulipristal acetate and a peptide from the co-repressor SMRT |
Heteromer P06401; | 100 | 1×2S0; | |||
| X-ray structure of human PPARgamma ligand binding domain-NCoR2 corepressor peptide co-crystals obta… |
Heteromer P37231; | 100 | ||||
| Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 and antagonist… |
Heteromer P19793; | 100 | 2×RHN; | |||
| Structural insights into the recruitment of SMRT by the co-repressor SHARP under phosphorylative re… |
Heteromer Q96T58; | 100 | ||||
| Solution structure of the SANT2 domain of the human nuclear receptor corepressor 2 (NCoR2), Northea… | monomer | 98.59 | ||||
| Solution Structure of the SMRT Deacetylase Activation Domain | monomer | 100 | ||||
5 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4a69.1.B | monomer | 0.70 | 100.00 | |||
| 2ltp.1.A | monomer | 0.66 | 98.57 | |||
| 1xc5.1.A | monomer | 0.65 | 100.00 | |||
| 8frv.1.B | monomer | 0.56 | 34.48 | |||
| 4czz.1.B | monomer | 0.55 | 30.84 | |||
10 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 4 | 4a69.1.B | monomer | 0.70 | 100.00 | |||
| Isoform 4 | 2ltp.1.A | monomer | 0.67 | 98.25 | |||
| Isoform 4 | 1xc5.1.A | monomer | 0.65 | 100.00 | |||
| Isoform 4 | 4czz.1.B | monomer | 0.55 | 30.84 | |||
| Isoform 4 | 8frv.1.B | monomer | 0.54 | 34.48 | |||
| Isoform 5 | 4a69.1.B | monomer | 0.68 | 100.00 | |||
| Isoform 5 | 2ltp.1.A | monomer | 0.66 | 98.57 | |||
| Isoform 5 | 1xc5.1.A | monomer | 0.64 | 100.00 | |||
| Isoform 5 | 4czz.1.B | monomer | 0.54 | 30.84 | |||
| Isoform 5 | 8jf5.1.B | monomer | 0.53 | 34.48 | |||